Geographutoxin I
| Internal ID | e75bb4e3-cd15-4cc7-9279-e9ffc47d8991 |
| Taxonomy | Organic acids and derivatives > Carboxylic acids and derivatives > Amino acids, peptides, and analogues > Peptides > Oligopeptides |
| IUPAC Name | (3S)-3-[[(2S)-2-amino-5-carbamimidamidopentanoyl]amino]-4-oxo-4-[[(1R,4S,7S,10S,12R,16S,19R,22S,25S,28S,31S,34R,37S,40S,43S,45R,49S,51R,55S,58R,65R,72R)-16,31,37,40-tetrakis(4-aminobutyl)-65-[[(2S)-1-amino-1-oxopropan-2-yl]carbamoyl]-7,22-bis(3-amino-3-oxopropyl)-4,25-bis(3-carbamimidamidopropyl)-28-(carboxymethyl)-12,45,51-trihydroxy-55-[(1R)-1-hydroxyethyl]-3,6,9,15,18,21,24,27,30,33,36,39,42,48,54,57,63,71-octadecaoxo-60,61,67,68,74,75-hexathia-2,5,8,14,17,20,23,26,29,32,35,38,41,47,53,56,64,70-octadecazahexacyclo[32.28.7.719,58.010,14.043,47.049,53]hexaheptacontan-72-yl]amino]butanoic acid |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C100H170N38O32S6/c1-46(76(108)149)118-87(160)62-40-171-172-41-63-88(161)122-52(15-3-7-25-101)80(153)128-61(36-74(147)148)85(158)121-55(19-12-30-116-99(111)112)79(152)123-57(21-23-71(106)143)84(157)131-64-42-173-175-44-66(132-86(159)60(35-73(145)146)127-77(150)51(105)14-11-29-115-98(109)110)91(164)134-67(92(165)135-75(47(2)139)97(170)138-39-50(142)34-70(138)96(169)137-38-49(141)33-69(137)94(167)124-54(17-5-9-27-103)78(151)119-53(81(154)129-63)16-4-8-26-102)45-176-174-43-65(90(163)133-62)130-82(155)56(20-13-31-117-100(113)114)120-83(156)58(22-24-72(107)144)125-93(166)68-32-48(140)37-136(68)95(168)59(126-89(64)162)18-6-10-28-104/h46-70,75,139-142H,3-45,101-105H2,1-2H3,(H2,106,143)(H2,107,144)(H2,108,149)(H,118,160)(H,119,151)(H,120,156)(H,121,158)(H,122,161)(H,123,152)(H,124,167)(H,125,166)(H,126,162)(H,127,150)(H,128,153)(H,129,154)(H,130,155)(H,131,157)(H,132,159)(H,133,163)(H,134,164)(H,135,165)(H,145,146)(H,147,148)(H4,109,110,115)(H4,111,112,116)(H4,113,114,117)/t46-,47+,48+,49+,50+,51-,52-,53-,54-,55-,56-,57-,58-,59-,60-,61-,62-,63-,64-,65-,66-,67-,68-,69-,70-,75-/m0/s1 |
| InChI Key | JXBJHMUQZOSJPJ-HTVVLJMASA-N |
| Popularity | 8 references in papers |
| Molecular Formula | C100H170N38O32S6 |
| Molecular Weight | 2609.10 g/mol |
| Exact Mass | 2608.1201173 g/mol |
| Topological Polar Surface Area (TPSA) | 1340.00 Ų |
| XlogP | -21.60 |
| Atomic LogP (AlogP) | -17.22 |
| H-Bond Acceptor | 44 |
| H-Bond Donor | 41 |
| Rotatable Bonds | 46 |
| 86394-16-3 |
| RefChem:819572 |
| (3S)-3-(((2S)-2-amino-5-carbamimidamido-1-hydroxypentylidene)amino)-4-hydroxy-4-(((1R,4S,7S,10S,12R,16S,19R,22S,25S,28S,31S,34R,37S,40S,43S,45R,49S,51R,55S,58R,65R,72R)-16,31,37,40-tetrakis(4-aminobutyl)-4,25-bis(3-carbamimidamidopropyl)-28-(carboxymethyl)-3,6,9,12,18,21,24,27,30,33,36,39,42,45,51,57,63,71-octadecahydroxy-55-((1R)-1-hydroxyethyl)-65-(C-hydroxy-N-((2S)-1-hydroxy-1-iminopropan-2-yl)carbonimidoyl)-7,22-bis(3-hydroxy-3-iminopropyl)-15,48,54-trioxo-60,61,67,68,74,75-hexathia-2,5,8,14,17,20,23,26,29,32,35,38,41,47,53,56,64,70-octadecazahexacyclo(32.28.7.719,58.010,14.043,47.049,53)hexaheptaconta-2,5,8,17,20,23,26,29,32,35,38,41,56,63,70-pentadecaen-72-yl)imino)butanoic acid |
| (3S)-3-(((2S)-2-amino-5-carbamimidamidopentanoyl)amino)-4-oxo-4-(((1R,4S,7S,10S,12R,16S,19R,22S,25S,28S,31S,34R,37S,40S,43S,45R,49S,51R,55S,58R,65R,72R)-16,31,37,40-tetrakis(4-aminobutyl)-65-(((2S)-1-amino-1-oxopropan-2-yl)carbamoyl)-7,22-bis(3-amino-3-oxopropyl)-4,25-bis(3-carbamimidamidopropyl)-28-(carboxymethyl)-12,45,51-trihydroxy-55-((1R)-1-hydroxyethyl)-3,6,9,15,18,21,24,27,30,33,36,39,42,48,54,57,63,71-octadecaoxo-60,61,67,68,74,75-hexathia-2,5,8,14,17,20,23,26,29,32,35,38,41,47,53,56,64,70-octadecazahexacyclo(32.28.7.719,58.010,14.043,47.049,53)hexaheptacontan-72-yl)amino)butanoic acid |
| 129129-65-3 |
| mu-conotoxin GIIIA |
| mu-Conotoxin G IIIA |
| CHEMBL4562161 |
| .mu.-Conotoxin G IIIA |
| Conotoxin G IIIA |
| There are more than 10 synonyms. If you wish to see them all click here. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | - | 0.6921 | 69.21% |
| Caco-2 | - | 0.8562 | 85.62% |
| Blood Brain Barrier | - | 0.7750 | 77.50% |
| Human oral bioavailability | - | 0.7143 | 71.43% |
| Subcellular localzation | Mitochondria | 0.5356 | 53.56% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8274 | 82.74% |
| OATP1B3 inhibitior | + | 0.9385 | 93.85% |
| MATE1 inhibitior | - | 0.8800 | 88.00% |
| OCT2 inhibitior | - | 0.6500 | 65.00% |
| BSEP inhibitior | + | 0.9631 | 96.31% |
| P-glycoprotein inhibitior | + | 0.7417 | 74.17% |
| P-glycoprotein substrate | + | 0.8814 | 88.14% |
| CYP3A4 substrate | + | 0.7425 | 74.25% |
| CYP2C9 substrate | - | 1.0000 | 100.00% |
| CYP2D6 substrate | - | 0.8168 | 81.68% |
| CYP3A4 inhibition | - | 0.9765 | 97.65% |
| CYP2C9 inhibition | - | 0.8685 | 86.85% |
| CYP2C19 inhibition | - | 0.8329 | 83.29% |
| CYP2D6 inhibition | - | 0.9012 | 90.12% |
| CYP1A2 inhibition | - | 0.8488 | 84.88% |
| CYP2C8 inhibition | + | 0.7580 | 75.80% |
| CYP inhibitory promiscuity | - | 0.9918 | 99.18% |
| UGT catelyzed | + | 0.8000 | 80.00% |
| Carcinogenicity (binary) | - | 0.8700 | 87.00% |
| Carcinogenicity (trinary) | Non-required | 0.5586 | 55.86% |
| Eye corrosion | - | 0.9823 | 98.23% |
| Eye irritation | - | 0.8952 | 89.52% |
| Skin irritation | - | 0.7470 | 74.70% |
| Skin corrosion | - | 0.9178 | 91.78% |
| Ames mutagenesis | - | 0.5264 | 52.64% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.6974 | 69.74% |
| Micronuclear | + | 0.8900 | 89.00% |
| Hepatotoxicity | + | 0.5300 | 53.00% |
| skin sensitisation | - | 0.8255 | 82.55% |
| Respiratory toxicity | + | 0.8667 | 86.67% |
| Reproductive toxicity | + | 0.8444 | 84.44% |
| Mitochondrial toxicity | + | 0.8625 | 86.25% |
| Nephrotoxicity | - | 0.5776 | 57.76% |
| Acute Oral Toxicity (c) | III | 0.5271 | 52.71% |
| Estrogen receptor binding | - | 0.6041 | 60.41% |
| Androgen receptor binding | + | 0.7635 | 76.35% |
| Thyroid receptor binding | + | 0.8030 | 80.30% |
| Glucocorticoid receptor binding | + | 0.8509 | 85.09% |
| Aromatase binding | + | 0.8237 | 82.37% |
| PPAR gamma | + | 0.8020 | 80.20% |
| Honey bee toxicity | - | 0.6434 | 64.34% |
| Biodegradation | - | 0.8000 | 80.00% |
| Crustacea aquatic toxicity | - | 0.5600 | 56.00% |
| Fish aquatic toxicity | - | 0.6179 | 61.79% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.82% | 98.95% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 99.76% | 96.09% |
| CHEMBL4296 | Q15858 | Sodium channel protein type IX alpha subunit | 99.61% | 96.11% |
| CHEMBL2072 | P35499 | Sodium channel protein type IV alpha subunit | 99.23% | 92.32% |
| CHEMBL5852 | Q96P65 | Pyroglutamylated RFamide peptide receptor | 98.85% | 85.00% |
| CHEMBL1628481 | P35414 | Apelin receptor | 98.67% | 97.89% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 98.53% | 97.23% |
| CHEMBL2821 | P00748 | Coagulation factor XII | 98.15% | 96.21% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 98.08% | 98.33% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 97.98% | 95.00% |
| CHEMBL236 | P41143 | Delta opioid receptor | 97.58% | 99.35% |
| CHEMBL3776 | Q14790 | Caspase-8 | 97.55% | 97.06% |
| CHEMBL4777 | P25929 | Neuropeptide Y receptor type 1 | 97.45% | 96.67% |
| CHEMBL4801 | P29466 | Caspase-1 | 97.44% | 96.85% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 97.33% | 94.45% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 96.72% | 100.00% |
| CHEMBL1801 | P00747 | Plasminogen | 96.71% | 92.44% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 96.51% | 98.05% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 96.46% | 96.90% |
| CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 96.24% | 88.42% |
| CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 96.17% | 95.50% |
| CHEMBL4071 | P08311 | Cathepsin G | 95.49% | 94.64% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 95.35% | 93.00% |
| CHEMBL4394 | Q9NYA1 | Sphingosine kinase 1 | 95.25% | 96.03% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 95.18% | 90.17% |
| CHEMBL4018 | P49146 | Neuropeptide Y receptor type 2 | 94.49% | 98.94% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 94.38% | 93.10% |
| CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 94.14% | 82.69% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 94.01% | 97.14% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 93.75% | 97.09% |
| CHEMBL4633 | P22001 | Voltage-gated potassium channel subunit Kv1.3 | 93.45% | 100.00% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 93.39% | 91.11% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 93.09% | 97.64% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 92.78% | 90.71% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 92.39% | 99.17% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 92.23% | 96.47% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 92.17% | 91.19% |
| CHEMBL1075317 | P61964 | WD repeat-containing protein 5 | 92.05% | 96.33% |
| CHEMBL3892 | Q99500 | Sphingosine 1-phosphate receptor Edg-3 | 91.81% | 97.29% |
| CHEMBL5043 | Q6P179 | Endoplasmic reticulum aminopeptidase 2 | 91.73% | 91.81% |
| CHEMBL1744525 | P43490 | Nicotinamide phosphoribosyltransferase | 91.61% | 96.25% |
| CHEMBL3976 | Q9UHL4 | Dipeptidyl peptidase II | 90.63% | 92.29% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 90.42% | 100.00% |
| CHEMBL3038477 | P67870 | Casein kinase II alpha/beta | 89.92% | 99.23% |
| CHEMBL4040 | P28482 | MAP kinase ERK2 | 89.90% | 83.82% |
| CHEMBL2068 | P29317 | Ephrin type-A receptor 2 | 89.83% | 97.49% |
| CHEMBL4374 | Q9Y5X4 | Photoreceptor-specific nuclear receptor | 89.81% | 85.00% |
| CHEMBL2443 | P49862 | Kallikrein 7 | 89.49% | 94.00% |
| CHEMBL2208 | P49137 | MAP kinase-activated protein kinase 2 | 87.92% | 95.20% |
| CHEMBL4302 | P08183 | P-glycoprotein 1 | 87.11% | 92.98% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 87.10% | 93.56% |
| CHEMBL1907600 | Q00535 | Cyclin-dependent kinase 5/CDK5 activator 1 | 87.09% | 93.03% |
| CHEMBL2413 | P32246 | C-C chemokine receptor type 1 | 86.92% | 89.50% |
| CHEMBL5028 | O14672 | ADAM10 | 86.84% | 97.50% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 86.77% | 100.00% |
| CHEMBL4625 | Q07817 | Apoptosis regulator Bcl-X | 86.57% | 99.77% |
| CHEMBL1907589 | P17787 | Neuronal acetylcholine receptor; alpha4/beta2 | 86.06% | 94.55% |
| CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 86.01% | 95.89% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 85.95% | 95.56% |
| CHEMBL3230 | O95977 | Sphingosine 1-phosphate receptor Edg-6 | 85.11% | 94.01% |
| CHEMBL4618 | P09960 | Leukotriene A4 hydrolase | 84.87% | 97.86% |
| CHEMBL3837 | P07711 | Cathepsin L | 84.24% | 96.61% |
| CHEMBL4330 | Q9NS75 | Cysteinyl leukotriene receptor 2 | 84.14% | 98.00% |
| CHEMBL3267 | P48736 | PI3-kinase p110-gamma subunit | 83.37% | 95.71% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 83.31% | 90.08% |
| CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 83.29% | 100.00% |
| CHEMBL3784 | Q09472 | Histone acetyltransferase p300 | 83.27% | 93.33% |
| CHEMBL4578 | Q14680 | Maternal embryonic leucine zipper kinase | 83.24% | 81.58% |
| CHEMBL2001 | Q9H244 | Purinergic receptor P2Y12 | 83.07% | 96.00% |
| CHEMBL299 | P17252 | Protein kinase C alpha | 82.09% | 98.03% |
| CHEMBL3468 | P55210 | Caspase-7 | 81.96% | 95.68% |
| CHEMBL4462 | Q8IXJ6 | NAD-dependent deacetylase sirtuin 2 | 81.69% | 90.24% |
| CHEMBL2111367 | P27986 | PI3-kinase p110-alpha/p85-alpha | 81.18% | 94.33% |
| CHEMBL5469 | Q14289 | Protein tyrosine kinase 2 beta | 81.14% | 91.03% |
| CHEMBL213 | P08588 | Beta-1 adrenergic receptor | 80.89% | 95.56% |
| CHEMBL3384 | Q16512 | Protein kinase N1 | 80.34% | 80.71% |
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 80.00% | 97.25% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 56843427 |
| LOTUS | LTS0246649 |
| wikiData | Q105136500 |